Discounted Cash Flow Rating

Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Werewolf Therapeutics, Inc. Common Stock (HOWL)

Pharmaceutical Preparations

https://www.werewolftx.com

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer.

200 TALCOTT AVENUE, 2ND FLOOR
WATERTOWN, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/30/2021

Market Cap

89,083,570

Shares Outstanding

36,190,000

Weighted SO

36,192,248

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

GLUE --.--%

DSGN --.--%

IKNA --.--%

STOK --.--%

EWTX --.--%

DBTX --.--%

CELC --.--%

CCCC --.--%

TALS --.--%

Beta

0.4640

Last Div

0.0000

Range

1.574-8.194

Chg

0.0300

Avg Vol

330427

Mkt Cap

89083570

Exch

NASDAQ

Country

US

Phone

617 952 0555

DCF Diff

-2.7677

DCF

4.7877

Div Yield

0.0000

P/S

9.5964

EV Multiple

0.1676

P/FV

0.8577

Div Yield %

0.0000

P/E

-1.6605

PEG

-0.3076

Payout

0.0000

Current Ratio

12.1297

Quick Ratio

12.1297

Cash Ratio

11.8251

DSO

21.4290

DIO

0.0000

Op Cycle

21.4290

DPO

293.7219

CCC

-272.2929

Gross Margin

0.8036

Op Margin

-6.2841

Pretax Margin

-5.7880

Net Margin

-5.7880

Eff Tax Rate

-0.0309

ROA

-0.3496

ROE

-0.4825

ROCE

-0.4101

NI/EBT

1.0000

EBT/EBIT

0.9211

EBIT/Rev

-6.2841

Debt Ratio

0.1720

D/E

0.2542

LT Debt/Cap

0.1948

Total Debt/Cap

0.2027

Int Coverage

-18.5662

CF/Debt

-1.5610

Equity Multi

1.4777

Rec Turnover

17.0330

Pay Turnover

1.2427

Inv Turnover

0.0000

FA Turnover

0.6908

Asset Turnover

0.0604

OCF/Share

-0.9482

FCF/Share

-0.9608

Cash/Share

3.1089

OCF/Sales

-4.4454

FCF/OCF

1.0133

CF Coverage

-1.5610

ST Coverage

-32.3917

CapEx Coverage

-75.4424

Div&CapEx Cov

-75.4424

P/BV

0.8577

P/B

0.8577

P/S

9.5964

P/E

-1.6605

P/FCF

-2.1305

P/OCF

-2.1620

P/CF

-2.1620

PEG

-0.3076

P/S

9.5964

EV Multiple

0.1676

P/FV

0.8577

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 03, 07:00 Werewolf Therapeutics Presents Preliminary Monotherapy Data from Phase 1/1b Clinical Trial Establishing Proof of Mechanism for WTX-124 at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting

Revenue Product Segmentation